Inventiva (IVA) Total Non-Current Liabilities (2018 - 2025)

Inventiva's (IVA) quarterly Total Non-Current Liabilities came in at $233.6 million in Q4 2025, up 108.4% year-on-year from $112.1 million in Q4 2024, and down 99.84% quarter-over-quarter from $146.5 billion in Q2 2025.

Inventiva (IVA) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends

Inventiva's Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $233.6 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 108.4% year-over-year to $233.6 million in Q4 2025; TTM through Dec 2025 was $233.6 million, a 108.4% increase from a year earlier, with the FY2025 full-year figure at $233.6 million, up 108.4% from the prior year.
  • Total Non-Current Liabilities fell to $233.6 million in Q4 2025 per IVA's latest filing, from $146.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $146.5 billion in Q2 2025 and bottomed at $11.7 million in Q4 2021.
  • The 5-year median for Total Non-Current Liabilities is $55.3 million (2023), against an average of $18.1 billion.
  • Across the five-year window, Total Non-Current Liabilities fell 28.62% in 2021 and jumped 93614.43% in 2022, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $11.7 million in 2021, then jumped by 245.99% to $40.6 million in 2022, then surged by 36.19% to $55.3 million in 2023, then jumped by 102.53% to $112.1 million in 2024, then surged by 108.4% to $233.6 million in 2025.
  • Per Business Quant, the three latest IVA Total Non-Current Liabilities figures stand at $233.6 million (Q4 2025), $146.5 billion (Q2 2025), and $112.1 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Inventiva 842.48 Mn 842.48 Mn - 233.57 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 233.57 Mn
Jun 30, 2025 146.48 Bn
Dec 31, 2024 112.08 Mn
Dec 31, 2023 55.34 Mn
Dec 31, 2022 40.63 Mn
Jun 30, 2022 15.60 Bn
Dec 31, 2021 11.74 Mn
Jun 30, 2021 16.65 Mn
Mar 31, 2021 16.76 Mn
Dec 31, 2020 16.45 Mn
Jun 30, 2020 1.97 Mn
Dec 31, 2019 1.89 Mn
Dec 31, 2018 3.58 Mn